Lee Jones, CEO Rebiotix, Inc & Glenn Taylor, Microbiologist, Taymount Clinic UK, Discuss Fecal Microbiota Transplant AKA Microbiota Restoration Therapy on C Diff Radio
Lee Jones, Founder, President and CEO of Rebiotix, Inc. has over thirty years of experience in the medical technology industry in large and small companies and academia. Rebiotix is developing a new category of biologic drugs that use live human-derived organisms to treat disease. Lead candidate RBX2660 (microbiota suspension) is currently undergoing clinical study for recurrent C. diff. infection.